PT-141 10000mcg/ml
Dosage Guide
About this medication
What is PT-141?
PT-141 (bremelanotide) is a synthetic peptide made of 7 amino acids. It binds to melanocortin receptors (MC3R and MC4R) in the hypothalamus, the part of the brain that helps regulate basic drives such as hunger, energy and sexual function. It is hypothesised to act on these central nervous system pathways rather than on blood flow.
Disclaimer: This information is provided solely as a description of what is currently understood about the origin and basic mechanisms of action of this compound. Some peptides are not ARTG-listed medicines. Importantly, for those compounds, there would be little or no high-quality clinical trials in humans that establish therapeutic effects, and therefore no medical claims can be implied by this description.
Important Information
A non-ARTG approved medication
PT-141 is not listed on the Australian Register of Therapeutic Goods (ARTG). Risks include allergic reactions, which can be severe.
What this means for you
PT-141 is a compounded medication. It is a Schedule 4 (Prescription Only) compound, meaning it can legally be prescribed by an Australian-registered medical doctor and must be dispensed by a licensed compounding pharmacy. Like most compounded medications, it is not listed on the ARTG.
- It has not undergone formal TGA registration trials, and may come with risks unique to medications lacking safety data.
- It is prescribed based on clinical judgement and your individual needs.
- We require your signed Non-ARTG Approved Medication Consent Form before dispensing.
Allergic reactions
If you notice any new allergy-like symptoms, especially soon after an injection, stop injecting and contact us on 02 9053 9444 before your next dose. If you have signs of a severe allergic reaction, call 000 immediately.
Learn about peptides and allergies →
Dosage Consult & Consent
Your dosage must be confirmed during a Nurse Dosage Consult. Repeats will not be issued until you have attended one.
Not booking? Read this first
The information provided in these online guides is general guidance only. Your prescribed dosage may differ based on your individual medical assessment.
Your dosage must be confirmed during a Nurse Dosage Consult.
Repeat prescriptions will not be issued without attendance to a minimum of one Dosage Consult.
No, I do not want to book
IMPORTANT INFORMATION
Restarting after a break
Some of the most severe allergic reactions happen when restarting after a break of 2 weeks or more.
Before you restart:
- Report any reaction you have had, however mild. Do not restart until our medical team has confirmed it is safe to do so.
Report an allergic reaction (Allergy Report Survey) - Restart on the Starting Dosage, not your previous or standard dose.
See the Starting Dosage ↓
Your dosage
PT-141 is used as required rather than on a set schedule, with no more than 1 dose every 24 hours and no more than 8 doses in 28 days. Everyone begins on the Starting Dosage. Your nurse will confirm your dosage during your Nurse Dosage Consult.
Read before you inject: dosage information
Starting dosage
When: 30 to 60 minutes before intended use
Volume: 0.1ml (10 units on syringe)
How often: No more than 1 dose every 24 hours
How many times per week: As required, no more than 8 doses in 28 days
Note
We intentionally start at a lower dose to assess how you tolerate the medication. You must begin with the recommended Starting Dosage and must not exceed it unless specifically instructed during your Nurse Dosage Consult.Standard dose
When: 30 to 60 minutes before intended use
Volume: Up to 0.25ml (25 units on syringe)
How often: No more than 1 dose every 24 hours
How many times per week: As required, no more than 8 doses in 28 days
Note
Only move to the standard dosage once you have tolerated the Starting Dosage, and as confirmed by our medical team. Do not use more than 1 dose every 24 hours, or more than 8 doses in 28 days.Injection areas
- Abdomen: lower left or right side of the abdomen, at least 2 to 3 cm away from the navel.
- Lower back: below the waistline, just above where the buttocks meet the lower back.
- Legs: upper inner or outer thighs.
- Arms: upper outer arm.
- Never inject directly into joints, ligaments, tendons, or lean muscle.
Your injections are all subcutaneous injections. They must be administered into fatty (subcutaneous) tissue only.
Rotate injection sites with each dose to reduce irritation and tissue damage.
Administration Protocol
Preparation
1. With provided alcohol wipe, wipe down the rubber part of the vial.
2. Remove protective cover and stopper from the needle.
Drawing
3. Draw the same amount of air into the syringe as required dosage amount.
4. Place needle into rubber part of bottle and push the plunger down to inject all the air. (SEE IMAGE 1)
5. Turn the bottle and syringe upside-down. Be sure the needle is fully immersed before drawing back.
6. Pull back on the plunger to required dosage (measure from the top of the plunger) (SEE IMAGE 2)
Injecting
7. Recheck the dose and add more to the syringe if necessary.
8. Choose a site for injection and wipe clean with alcohol wipe.
9. Insert the needle fully into the pinched skin at a 90-degree angle (straight up and down) and slowly push on the plunger with your thumb until the bottom of the syringe is reached. (SEE IMAGE 3)
10. Be sure to vary the exact injection site each time.
Disposal
Do not cap the needle. Drop the entire syringe and needle into your container for used “sharps” equipment.
Do NOT put this container in the recycling bin. Check with your local health department for specific disposal instructions in your community.
Contraindications
Make sure to check that none of these apply to you when starting this medication:
- You are allergic or have had significant past reactions to PT-141 (bremelanotide), benzyl alcohol, sodium hydroxide or hydrochloric acid
- You have high blood pressure that is not well controlled
- You have known heart or blood vessel disease
- You are pregnant, trying to conceive, or breastfeeding
- You are under 18 years of age
Talk to our medical team first if you:
- Are at high risk of heart disease
- Take naltrexone tablets for alcohol or opioid dependence, as PT-141 may stop them working properly
Side effects
Common side effects
- Nausea. This is the most common side effect and usually improves with later doses.
- Flushing
- Injection-related side effects: redness, bruising or itching at the injection site
- Headache
- Vomiting
Uncommon side effects
- A temporary rise in blood pressure and slower heart rate after a dose, which usually settles within about 12 hours
- Darkening of small patches of skin (for example on the face, gums or breasts). This is more likely with frequent use. Tell us if you notice it.
- Allergic reactions to PT-141 can be severe and life-threatening. Contact us immediately if you notice rash, hives, itching, swelling, or welts at injection sites. Do not wait to see if symptoms resolve.
- Peptides carry risks, including severe allergic reactions. Learn about peptides and allergies →
Allergic Reaction?
If you believe you might be experiencing an allergic reaction, call us immediately
02 9053 9444
Severe Allergic Reaction?
If you believe you might be experiencing a severe allergic reaction (difficulty breathing, obstruction of airways), call Emergency Services immediately
000
Don'ts
- Do not share or reuse syringes. Dispose of them safely after every injection.
- Do not share medication vials with anyone.
- Do not use more than 1 dose every 24 hours.
- Do not use more than 8 doses in 28 days.
- Do not inject more than 0.25ml (25 units on syringe) at one time.
- Do not continue injections if you experience persistent or concerning side effects. Contact our medical team promptly to discuss.
- Do not use the medication past the expiry date.
- Do not shake the vial. Excessive shaking will render the medication ineffective.
Storage & Consumables
Storing your medication
- Refrigerate your medication immediately upon receipt. Do NOT freeze.
- Keep the vial out of direct sunlight.
What’s in your pack
- Syringes
- Alcohol wipes
- Peptide vial(s)
Disposal of sharps containers
- Do not cap the needle. Drop the entire syringe and needle into your container for used “sharps” equipment.
- Do NOT put this container in the recycling bin. Check with your local health department for specific disposal instructions in your community.
Expiry
Each vial has 2 expiry dates (a maximum expiry date, and an expiry date from date of first use). Do not use your vial beyond the earliest expiry date:
- Unopened vial: use by the expiry date printed on the vial (maximum expiry date).
- After first use: discard 28 days from the date of first injection.
- Please ensure you begin using your vial well before the printed expiry date. The 28-day period after opening does not extend the original expiry date.